What is the recommended treatment for catatonia?

Treatment for Catatonia

Benzodiazepines, specifically lorazepam, are the first-line treatment for catatonia, followed by electroconvulsive therapy (ECT) for patients who fail to respond adequately to benzodiazepines. 1, 2

First-Line Treatment: Benzodiazepines

Lorazepam is the primary pharmacological intervention for catatonia. The evidence demonstrates a robust treatment effect, with an overall remission rate of 55% and response rate of 77% 2. Recent meta-analysis shows benzodiazepines produce an average reduction of 11.88 points on the Bush Francis Catatonia Rating Scale (BFCRS) with a large effect size (Cohen's d = -3.15) 2.

Dosing Strategy

• Starting dose: Begin with lorazepam 1-2 mg orally, subcutaneously, or intravenously
• Dose escalation: Increase rapidly based on response, typically reaching 8 mg/day (median effective dose) 2
• Dose range: 2-60 mg/day has been used in clinical practice, with no established maximum dose 3, 2
• Key principle: Continue escalating until either adequate symptom improvement occurs or side effects emerge 3
• No clear dose-response relationship exists, so titration should be individualized based on clinical response rather than targeting a specific dose 2

Administration Route

Lorazepam can be given orally, subcutaneously, intramuscularly, or intravenously depending on the clinical situation and patient's ability to take oral medication 3, 1.

Second-Line Treatment: Electroconvulsive Therapy (ECT)

ECT should be pursued for patients with partial or no response to lorazepam, regardless of ECT accessibility. 3 ECT is particularly indicated in:

• Lorazepam-resistant catatonia (approximately 30% of cases) 4
• Life-threatening presentations including refusal to eat or drink, severe medical instability 5
• Malignant catatonia and neuroleptic malignant syndrome 5, 1

ECT Parameters (for adolescents, extrapolated to adults)

• Frequency: Begin with 2-3 times weekly 5
• Electrode placement: Start with unilateral (nondominant hemisphere) placement; switch to bilateral if response is inadequate or in urgent situations (severe malnutrition, catatonia with life-threatening features) 5
• Course duration: Typical course consists of 10-12 treatments, though response may occur earlier or later 5
• Urgent indications for bilateral ECT from onset: Florid psychosis, severe suicidality, refusal to eat/drink, or catatonia itself 5

Treatment Algorithm

1. Immediate initiation: Start lorazepam as soon as catatonia is suspected using evidence-based rating scales (Bush Francis Catatonia Rating Scale) 3, 1

2. Rapid titration: Increase lorazepam dose every 1-2 days based on symptom response, monitoring with serial BFCRS assessments 3

3. Response assessment: Evaluate after 3-5 days of adequate lorazepam dosing 6

4. Pursue ECT: If partial or no response to lorazepam, initiate ECT consultation and planning immediately—do not delay 3

5. Adjunctive considerations: Other agents (antipsychotics with caution, other benzodiazepines) may be considered while awaiting ECT access, but should not delay ECT pursuit 3

Special Populations

Pediatric Catatonia

The same treatment principles apply: lorazepam first-line, ECT for non-responders 3, 6. In adolescents, ECT requires meeting three criteria: appropriate diagnosis (including catatonia), severe/disabling symptoms, and typically failure of at least two adequate medication trials—though ECT may be considered earlier when life-threatening symptoms are present 5.

Catatonia in Schizophrenia

ECT may be considered when prominent affective symptoms or catatonia is present, or when patients cannot tolerate neuroleptic medication at therapeutic doses 7, 5. Benzodiazepines remain first-line, with ECT as the definitive treatment for non-responders 7.

Critical Pitfalls to Avoid

• Do not mistake catatonic symptoms for negative symptoms of schizophrenia or Parkinsonism from antipsychotics 7—this delays appropriate treatment
• Do not delay ECT pursuit while trying multiple other pharmacological agents in lorazepam non-responders 3
• Do not arbitrarily cap lorazepam dose—there is no established maximum, and some patients require very high doses 3
• Do not taper lorazepam too quickly once symptoms improve, as this can cause symptom re-emergence 6
• Avoid antipsychotics in acute catatonia unless specifically treating underlying psychosis, as they can worsen catatonia or precipitate neuroleptic malignant syndrome 1

Monitoring

Use standardized rating scales (Bush Francis Catatonia Rating Scale) for initial diagnosis and serial assessment during treatment 3, 1. Monitor for medical complications including dehydration, malnutrition, rhabdomyolysis, and venous thromboembolism, which require concurrent medical management 1.